Just doing some comparison and trying not to cross promote or name drop but that's not really possible if trying to find some semblance of a credible comparison.
Essentially just looking at the value of the recent agreement with Priceline. I fully anticipate Chemist Warehouse will be signed as a distributor within the next three months as they cannot afford their competition to gain market share dominance of new pharmaceutical cannabis related products.
Ref: BOD, Priceline 19th Sep Agreement, Chemist Warehouse 9th Nov Agreement.
Record revenue of $1.22 million for the last quarter of 2018, underpinned by an expansion of its product range Bod achieves record revenue of $1.22m for the Dec 2018 quarter – with product sales comprising$766,000. Representing a 260% increase on Q1 FY2018 and 129% Q2 FY2018 expansion of natural medicines range, newdistribution deals with Priceline and Chemist Warehouse.
This gives a relative (but inaccurate) indication of the kind of % sales increase to be expected from Medlab.
Medlab have sales revenue around $1.6mil for the Dec quarter so their sales should eclipse BOD if rolled out and marketed correctly.
Medlab next quarter total estimated cash outflows -$3,495,000
Cash on hand as of Dec quarter $16,116,000. > 1 year working capital without any revenue or tax incentives whatsoever. If Including current revenue, Medlab likely has > 24 months working capital. Very healthy balance sheet.
I anticipate Medlab to still be negative Net revenue 1st quarter 2019 but to then break even 2nd quarter 2019. After that I anticipate positive net cash flow sometime in 2nd half 2019. Half yearly report will be really interesting. Until then it's buy the dips and continue accumulating. Expecting a very solid back half 2019 with early 2020 to be a breakout period and get back to the $1.00 SP range based on sales alone and not taking into account further research developments or alternative distribution agreements.
Above is not advice and assumptions were made that may be inaccurate.
GLA
- Forums
- ASX - By Stock
- MDC
- Ann: Medlab to Expand Nutraceutical Range into 2,100 Pharmacies
Ann: Medlab to Expand Nutraceutical Range into 2,100 Pharmacies, page-5
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
MDC (ASX) Chart |
Day chart unavailable